FDA Inspection
Anesta LLCAnesta LLC – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns Anesta LLC, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e57e3660-d212-4804-bff5-2410de312076
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012740
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anesta LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2024 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| December 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 16, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Anesta LLC
- FDA Inspection 1248477 - 2024-08-30
- FDA Inspection 1114607 - 2019-12-10
- FDA Inspection 1094891 - 2019-05-24
- FDA Inspection 914960 - 2015-01-16
- FDA Inspection 793454 - 2012-08-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.